Prevention and control of noncommunicable diseases is a public health priority worldwide. However, data have shown steady increases in noncommunicable diseases, especially obesity and diabetes, in many countries.
1-4 Diabetes prevalence in China increased from less than 1% in the 1980s to almost 11% in 2013.
5-9 In 2013, China reported having the largest number of patients with diabetes and spending the second highest amount on diabetes and its complications worldwide.
8,10,11 In addition, the population of patients with prediabetes represents a large reservoir of patients at risk of diabetes. Previous research showed low rates of awareness, treatment, and control of diabetes in China,
6-8 compared with the United States.
12 Previous national surveillance data described the prevalence and treatment of diabetes in China in 2013.
8 Another survey reported estimated diabetes prevalence of 11.2% and prediabetes prevalence of 35.2% in 2015.
13